ストックスクリーナーアプリを入手
2.19
17.74%
0.33
プレマーケット:
2.14
-0.05
-2.28%
前日終値:
$1.86
開ける：
$1.9
24時間の取引高:
1.08M
Relative Volume:
3.63
時価総額：
$36.51M
収益：
-
当期純損益:
$-9.70M
株価収益率:
-1.9909
EPS:
-1.1
ネットキャッシュフロー:
$-8.57M
1週間 パフォーマンス:
+46.98%
1か月 パフォーマンス:
+65.91%
6か月 パフォーマンス:
+39.49%
1年 パフォーマンス:
-26.51%
1日の値動き範囲:
$1.89
$2.20
1週間の範囲:
$1.50
$2.20
52週間の値動き範囲:
$0.8099
$4.07
Marker Therapeutics Inc Stock (MRKR) Company Profile
名前
Marker Therapeutics Inc
セクター
電話
(713) 400-6400
住所
2450 HOLCOMBE BLVD, HOUSTON, TX
MRKR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
2.19 | 31.01M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-05 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-25 | 開始されました | Piper Sandler | Overweight |
| 2021-03-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-05-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | 開始されました | ROTH Capital | Buy |
| 2019-03-01 | 開始されました | Janney | Buy |
| 2018-12-03 | アップグレード | Piper Jaffray | Neutral → Overweight |
すべてを表示
Marker Therapeutics Inc (MRKR) 最新ニュース
Marker Therapeutics, Inc. (MRKR) now trades above golden cross: Time to buy? - MSN
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK
Is Marker Therapeutics Inc GX1 a good long term investmentMarket Sentiment Shifts & Buy Sell Signal Notifications - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Brookline Capital raises Marker Therapeutics stock price target to $5.60 By Investing.com - Investing.com Canada
Marker Therapeutics Reports Positive Phase 1/2 Clinical Study Results for Multi-Antigen Targeted T Cells in Pancreatic Cancer Patients - Quiver Quantitative
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - The Manila Times
Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to Hold - Defense World
MRKR stock touches 52-week low at $1.8 amid market challenges - MSN
Why Marker Therapeutics Inc stock remains undervaluedMarket Trend Review & Verified Stock Trade Ideas - moha.gov.vn
Trade Recap: How Marker Therapeutics Inc GX1 stock reacts to monetary easing2025 Major Catalysts & Smart Investment Allocation Tips - moha.gov.vn
Nasdaq Moves: Is Mineralys Therapeutics Inc stock a safe investment in uncertain marketsJuly 2025 Outlook & Real-Time Volume Spike Alerts - moha.gov.vn
MRKR stock touches 52-week low at $2.4 amid challenging year - MSN
Technical Analysis: Amber Enterprises India Limited (AMBER)Stock Correlation Metrics & Superior Return Stocks - bollywoodhelpline.com
Moving Average Crossover Confirms Uptrend in Dharani Sugars and Chemicals LimitedEnergy Sector Updates & Interactive Charts for Smarter Trading - bollywoodhelpline.com
Fed Watch: Can Marker Therapeutics Inc stock deliver 10 annual returnsQuarterly Profit Report & Fast Gaining Stock Reports - moha.gov.vn
Can Prabhu Steel Industries Limited Bounce Back From Weekly LowFundamental Stock Analysis & Low Cost Trading Tips - bollywoodhelpline.com
Svam Software Limited Approaches Psychological Resistance LevelEconomic Impact on Stocks & Free Quantitative Trading Strategies - Bollywood Helpline
Sentiment Review: Will Marker Therapeutics Inc. stock benefit from green energy trendsPrice Action & Consistent Income Trade Ideas - moha.gov.vn
How sustainable is Marker Therapeutics Inc. stock dividend payoutJuly 2025 Sector Moves & Verified Momentum Watchlists - Улправда
Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Key Lessons & Capital Efficiency Focused Ideas - Улправда
What insider trading reveals about Marker Therapeutics Inc. stockRisk Management & Real-Time Stock Price Movement Reports - Улправда
Risk Report: Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
Will Marker Therapeutics Inc. stock benefit from green energy trends2025 Market Outlook & AI Driven Stock Reports - Улправда
Risk Hedge: What insider trading reveals about Marker Therapeutics Inc. stockQuarterly Earnings Report & Proven Capital Preservation Tips - Улправда
Will Marker Therapeutics Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & High Conviction Trade Alerts - DonanımHaber
Marker Therapeutics Earnings Notes - Trefis
Can Marker Therapeutics Inc. stock sustain market leadershipWeekly Trend Report & Community Consensus Trade Signals - Улправда
Is Marker Therapeutics Inc. stock trading near support levelsJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Retail Surge: Can Marker Therapeutics Inc. stock surprise with earnings upside2025 Volatility Report & High Accuracy Swing Trade Signals - ulpravda.ru
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - RTTNews
How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда
Here's Why Marker Therapeutics (NASDAQ:MRKR) Must Use Its Cash Wisely - Yahoo Finance
US High Growth Tech Stocks To Watch December 2025 - simplywall.st
Marker Therapeutics, Inc. (NASDAQ:MRKR) Receives Consensus Rating of “Buy” from Analysts - Defense World
How strong is Marker Therapeutics Inc stock balance sheet2025 Top Decliners & Weekly High Return Opportunities - moha.gov.vn
Panic Selling: Is Marker Therapeutics Inc stock supported by strong cash flows2025 Pullback Review & Reliable Momentum Entry Alerts - moha.gov.vn
Published on: 2025-12-13 20:42:44 - moha.gov.vn
What drives Marker Therapeutics Inc GX1 stock priceDividend Stability Analysis & Consistent Triple Returns - earlytimes.in
FY2025 Earnings Forecast for MRKR Issued By HC Wainwright - Defense World
Marker Therapeutics (NASDAQ:MRKR) Coverage Initiated at HC Wainwright - Defense World
H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock By Investing.com - Investing.com Canada
HC Wainwright & Co. Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq
MRKR: HC Wainwright & Co. Initiates Coverage with a 'Buy' Rating - GuruFocus
Check Out Lam Research Corp (LRCX)’s Trade Data Rather Than the Analysts’ Views - setenews.com
Why Marker Therapeutics Inc. stock remains on watchlistsWeekly Trend Report & AI Forecasted Stock Moves - Newser
How analysts revise price targets for Marker Therapeutics Inc. (GX1) stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Business Upturn
Is Marker Therapeutics Inc. stock supported by innovation pipelineMarket Performance Recap & Advanced Technical Signal Analysis - Newser
Is Marker Therapeutics Inc. (GX1) stock good for long term investingJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Marker Therapeutics Inc (MRKR) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):